US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 2.2500
  • -0.1300-5.46%
Close Jun 7 16:00 ET
  • 2.3400
  • +0.0900+4.00%
Post 16:35 ET
32.69MMarket Cap-1890P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-1.01%98K
-11.11%424K
1,166.67%76K
-31.74%114K
7.14%135K
-44.38%99K
-48.76%477K
-97.80%6K
25.56%167K
-57.29%126K
Operating revenue
-1.01%98K
-11.11%424K
1,166.67%76K
-31.74%114K
7.14%135K
-44.38%99K
-48.76%477K
-97.80%6K
25.56%167K
-57.29%126K
Cost of revenue
Gross profit
Operating expense
25.18%7.48M
-14.64%29.68M
-13.54%6.91M
-33.18%6.35M
24.25%10.45M
-32.64%5.97M
-12.73%34.77M
-12.38%7.99M
-12.84%9.5M
-14.48%8.41M
Selling and administrative expenses
16.36%3.77M
-18.38%13.38M
4.69%3.89M
-23.37%3.03M
-25.20%3.22M
-26.65%3.24M
-19.27%16.39M
-22.61%3.71M
-20.65%3.95M
-10.11%4.31M
-General and administrative expense
16.36%3.77M
-18.38%13.38M
----
----
----
--3.24M
--16.39M
----
----
----
Research and development costs
35.63%3.71M
-11.30%16.31M
-29.35%3.02M
-40.17%3.32M
76.07%7.23M
-38.59%2.73M
-5.93%18.39M
-1.04%4.28M
-6.27%5.55M
-18.62%4.11M
Operating profit
-25.62%-7.38M
14.69%-29.26M
14.43%-6.83M
33.20%-6.23M
-24.51%-10.32M
32.40%-5.88M
11.86%-34.3M
9.74%-7.98M
13.32%-9.33M
13.15%-8.29M
Net non-operating interest income expense
Other net income (expense)
333.08%1.14M
281.82%1.39M
188.14%680K
108.97%163K
438.46%280K
8,866.67%263K
368.89%363K
807.69%236K
322.86%78K
175.36%52K
Other non- operating income (expenses)
333.08%1.14M
281.82%1.39M
188.14%680K
108.97%163K
438.46%280K
8,866.67%263K
368.89%363K
807.69%236K
322.86%78K
175.36%52K
Income before tax
-11.21%-6.24M
17.86%-27.87M
20.60%-6.15M
34.40%-6.07M
-21.89%-10.04M
35.45%-5.61M
24.01%-33.93M
12.15%-7.75M
35.17%-9.26M
22.93%-8.24M
Income tax
0
0
0
0
0
0
102.90%13K
102.90%13K
0
0
Net income
-11.15%-6.25M
-22.59%-28.45M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
68.35%-23.21M
14.04%-9.95M
55.56%-9.46M
57.46%-8.48M
Net income continuous Operations
-11.21%-6.24M
17.89%-27.87M
20.73%-6.15M
34.40%-6.07M
-21.89%-10.04M
35.45%-5.61M
23.22%-33.95M
7.30%-7.76M
35.17%-9.26M
22.93%-8.24M
Net income discontinuous operations
20.00%-8K
-105.40%-580K
98.35%-36K
-151.47%-513K
91.70%-20K
-100.07%-10K
136.86%10.74M
31.71%-2.18M
97.09%-204K
97.39%-241K
Minority interest income
Net income attributable to the parent company
-11.15%-6.25M
-22.59%-28.45M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
68.35%-23.21M
14.04%-9.95M
55.56%-9.46M
57.46%-8.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.15%-6.25M
-22.59%-28.45M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
68.35%-23.21M
14.04%-9.95M
55.56%-9.46M
57.46%-8.48M
Basic earnings per share
91.38%-0.15
61.81%-2.78
86.82%-0.4389
31.63%-2.01
-17.49%-3.09
-215.23%-1.74
71.61%-7.28
15.91%-3.33
60.16%-2.94
62.54%-2.63
Diluted earnings per share
91.38%-0.15
61.81%-2.78
86.82%-0.4389
31.63%-2.01
-17.49%-3.09
-215.23%-1.74
71.61%-7.28
15.91%-3.33
60.16%-2.94
62.54%-2.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -1.01%98K-11.11%424K1,166.67%76K-31.74%114K7.14%135K-44.38%99K-48.76%477K-97.80%6K25.56%167K-57.29%126K
Operating revenue -1.01%98K-11.11%424K1,166.67%76K-31.74%114K7.14%135K-44.38%99K-48.76%477K-97.80%6K25.56%167K-57.29%126K
Cost of revenue
Gross profit
Operating expense 25.18%7.48M-14.64%29.68M-13.54%6.91M-33.18%6.35M24.25%10.45M-32.64%5.97M-12.73%34.77M-12.38%7.99M-12.84%9.5M-14.48%8.41M
Selling and administrative expenses 16.36%3.77M-18.38%13.38M4.69%3.89M-23.37%3.03M-25.20%3.22M-26.65%3.24M-19.27%16.39M-22.61%3.71M-20.65%3.95M-10.11%4.31M
-General and administrative expense 16.36%3.77M-18.38%13.38M--------------3.24M--16.39M------------
Research and development costs 35.63%3.71M-11.30%16.31M-29.35%3.02M-40.17%3.32M76.07%7.23M-38.59%2.73M-5.93%18.39M-1.04%4.28M-6.27%5.55M-18.62%4.11M
Operating profit -25.62%-7.38M14.69%-29.26M14.43%-6.83M33.20%-6.23M-24.51%-10.32M32.40%-5.88M11.86%-34.3M9.74%-7.98M13.32%-9.33M13.15%-8.29M
Net non-operating interest income expense
Other net income (expense) 333.08%1.14M281.82%1.39M188.14%680K108.97%163K438.46%280K8,866.67%263K368.89%363K807.69%236K322.86%78K175.36%52K
Other non- operating income (expenses) 333.08%1.14M281.82%1.39M188.14%680K108.97%163K438.46%280K8,866.67%263K368.89%363K807.69%236K322.86%78K175.36%52K
Income before tax -11.21%-6.24M17.86%-27.87M20.60%-6.15M34.40%-6.07M-21.89%-10.04M35.45%-5.61M24.01%-33.93M12.15%-7.75M35.17%-9.26M22.93%-8.24M
Income tax 000000102.90%13K102.90%13K00
Net income -11.15%-6.25M-22.59%-28.45M37.78%-6.19M30.39%-6.58M-18.66%-10.06M-220.39%-5.62M68.35%-23.21M14.04%-9.95M55.56%-9.46M57.46%-8.48M
Net income continuous Operations -11.21%-6.24M17.89%-27.87M20.73%-6.15M34.40%-6.07M-21.89%-10.04M35.45%-5.61M23.22%-33.95M7.30%-7.76M35.17%-9.26M22.93%-8.24M
Net income discontinuous operations 20.00%-8K-105.40%-580K98.35%-36K-151.47%-513K91.70%-20K-100.07%-10K136.86%10.74M31.71%-2.18M97.09%-204K97.39%-241K
Minority interest income
Net income attributable to the parent company -11.15%-6.25M-22.59%-28.45M37.78%-6.19M30.39%-6.58M-18.66%-10.06M-220.39%-5.62M68.35%-23.21M14.04%-9.95M55.56%-9.46M57.46%-8.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.15%-6.25M-22.59%-28.45M37.78%-6.19M30.39%-6.58M-18.66%-10.06M-220.39%-5.62M68.35%-23.21M14.04%-9.95M55.56%-9.46M57.46%-8.48M
Basic earnings per share 91.38%-0.1561.81%-2.7886.82%-0.438931.63%-2.01-17.49%-3.09-215.23%-1.7471.61%-7.2815.91%-3.3360.16%-2.9462.54%-2.63
Diluted earnings per share 91.38%-0.1561.81%-2.7886.82%-0.438931.63%-2.01-17.49%-3.09-215.23%-1.7471.61%-7.2815.91%-3.3360.16%-2.9462.54%-2.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg